1 天
Clinical Trials Arena on MSNYingli Pharma gains FDA approval for Phase III trial of r/r PTCL drug candidateYingli Pharma has obtained US FDA approval for a Phase III trial of linperlisib for R/R peripheral T-cell lymphoma (PTCL).
A bill that would permit lawsuits of up to $5 million against abortion pill manufacturers heads for a final vote in the ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果